Navigation Links
Pollogen Announces Appointment of Ms. Yfat Scialom as Chief Executive Officer
Date:8/5/2008

TEL AVIV, Israel, BADAJOZ, Spain and SINGAPORE, August 5 /PRNewswire/ -- Pollogen Ltd. announced that Ms. Yfat Scialom has been appointed as the new Chief Executive Officer effective July 20, 2008.

Ms. Scialom comes to Pollogen with 20 years of experience in sales, marketing and senior management in the medical and aesthetic field. She previously served as VP of Marketing and Sales at UltraShape Ltd., a leader in non-invasive body contouring solutions. Ms. Scialom established the marketing and sales infrastructure and was responsible for the successful launch of the Company's products, defining the branding, positioning, and the formation of a global distribution network in 50 countries and 3 direct subsidiaries, driving sales from zero to tens of millions of dollars.

Ms. Scialom formerly served as a Senior Marketing Director of Oridion BreathID, a manufacturer of medical equipment in the field of Gastroenterology. Prior to Oridion, she acted as the General Manager of Sunlight Medical Europe, a medical device company in the field of ultrasound. Ms. Scialom holds a B.Sc. in Economics and Management from the Hebrew University of Jerusalem and an MBA from the Ben-Gurion University.

While Ms. Scialom will be the new CEO, Dr. Zion Azar and Mr. Pini Shalev will maintain an active role in their current positions as Chairman and CTO.

"As Pollogen and its sales of TriPollar(TM) based systems continue to grow, we feel that Ms. Scialom is the right CEO for the Company. We were impressed by Ms. Scialom's proven track record and believe that she will bring leadership and ingenuity as well as continue to build the Company and expand its sales and infrastructure," stated Dr. Zion Azar, Pollogen's Chairman. "We believe that Ms. Scialom will play a key role in maintaining TriPollar as the industry gold standard. We look forward to have Ms. Scialom as part of our Pollogen's management team and to her contribution to the continued growth and developm
'/>"/>

SOURCE Pollogen Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Molecular Biometrics Announces Results of Parkinsons Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology
2. SemBioSys announces second quarter 2008 financial and operational results
3. Reminder: Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
4. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
5. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
6. NanoLogix Inc. Announces Joint Development With CL Solutions and First Sales of Rapid Detection Kits
7. CryoLife Announces Management Promotions
8. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
9. Cantel Medical Announces Management Succession at Crosstex Healthcare Disposables Subsidiary
10. Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
11. Novavax Announces Closing of $18 Million Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Nashville Fertility Center announced that Dr. George ... Society for Reproductive Medicine (ASRM), a leading professional organization ... In his new role as treasurer, Dr. Hill ... will have a voice in furthering the mission of ... since 1984 when he joined while conducting fellowship training ...
(Date:12/24/2014)... December 23, 2014 PharmaBoardroom,s ... out today and available for free download , digs ... change and growth in the sector today. One ... successes has been in developing a homegrown pharmaceutical manufacturing base, ... production still remains some way off. A cursory comparison with ...
(Date:12/22/2014)... Md. , Dec. 22, 2014 /PRNewswire/ ... SYN), a developer of pathogen-specific therapies for ... on protecting the microbiome, today announced positive ... Phase 1a clinical trial of SYN-004, the ... prevention of Clostridium difficile (C. difficile) ...
(Date:12/22/2014)... 2014 The American Journal ... original research, reviews and editorials addressing developments and ... today published a provocative article exploring the role ... and potential treatment of prostate cancer. , ... proposes the possibility that there could be a ...
Breaking Biology Technology:Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... Capital Partners and Versant Ventures Lead ... Help Transform Clinical Microbiology, MADISON, Wis., Sept. 12 ... in equity financing. The round,was led by CHL Medical Partners, ... also participating. In,conjunction, CHL,s Ron Lennox will become chairman of ...
... raw materials for the chemical industry and generate power ... manufacturing processes. , Making synthesis gas - a blend ... step in turning natural gas or biomass into bulk ... and ammonia, which are the feedstock of the global ...
... in Clean Technology and Global Business Potential, ... Inc., a,leading algal biotechnology company, today announced that ... the GoingGreen 100 Top Private Companies for,2007. The ... the,AlwaysOn editorial panel. In order to be eligible ...
Cached Biology Technology:OpGen Announces $23.6 Million Series A Financing 2OpGen Announces $23.6 Million Series A Financing 3A POX on syn 2Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner 2Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner 3
(Date:12/17/2014)... 2014  HITLAB SM announced today its ... to confirm its adherence to current U.S. Food ... HITLAB to conduct regulated smart device and smart ... patient safety and research quality. "HITLAB ... and delivery with innovative technology," said Laura ...
(Date:12/17/2014)... 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend upcoming ... medical sensors in biomedical applications. Chemical sensors help ... correct diagnosis during surgical procedures. The Global Chemical ...
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research ... announced the addition of the "Global Facial ... http://photos.prnewswire.com/prnh/20130307/600769 ... the identification of individuals. Facial recognition system measures ... as nose, jaw edges, mouth, and the distance ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... /PRNewswire-iReach/ -- We,ve heard they may be easy enough ... yoga facial exercises regimen, the whole face and neck ... exercises using the fingertips are oftentimes performed to generate ... really work? (Photo: http://photos.prnewswire.com/prnh/20130710/CG44610 ) ...
... people with schizophrenia have marked problems with motivation, ... These negative symptoms of schizophrenia can be disabling ... For many years it was thought this was ... with successful goal attainment. However, recent laboratory studies ...
... Lithuania , July 10, 2013   ... identification technologies, today announced new releases across their ... including: MegaMatcher 4.5 multi-biometric SDK for large-scale applications, ... facial identification, VeriEye 2.7 for iris identification and ...
Cached Biology News:Getting Rid of Facial Wrinkles and Toning Up in 2013 2Getting Rid of Facial Wrinkles and Toning Up in 2013 3Calculating the value of effortful behavior: A clue to schizophrenia-related disability? 2Neurotechnology Announces MegaMatcher Accelerator 6.0 High-speed, High-volume Multibiometric Identification Solution and Updates to Entire Biometric Product Line 2Neurotechnology Announces MegaMatcher Accelerator 6.0 High-speed, High-volume Multibiometric Identification Solution and Updates to Entire Biometric Product Line 3Neurotechnology Announces MegaMatcher Accelerator 6.0 High-speed, High-volume Multibiometric Identification Solution and Updates to Entire Biometric Product Line 4
Performance, mycoplasma, virus, and endotoxin tested...
... 10X BlueJuice Gel ... for easy loading and ... in agarose or native ... buffer features higher density ...
... Cloning is the most ... cloning PCR products. TOPO ... Blunt TOPO vectors are ... with topoisomerase I. This ...
ready-to-use solution...
Biology Products: